A term used to describe the narrowing of arteries due to plaque build-up is:

Choice A rationale

Myocardial infarction involves ischemia and necrosis of the heart muscle, often presenting with chest pain that may radiate to the left arm or jaw. While epigastric pain can occur, the negative electrocardiogram and normal cardiac enzymes (such as Troponin I < 0.04 ng/mL) significantly lower the probability of a cardiac event. The specific trigger of a high-fat meal and radiation to the back is much more characteristic of gallbladder disease than coronary occlusion.

Choice B rationale

Cholecystitis is inflammation of the gallbladder, often caused by gallstones obstructing the cystic duct. High-fat meals trigger the release of cholecystokinin, which causes the gallbladder to contract to release bile. If obstructed, this contraction causes sharp pain in the right upper quadrant that frequently radiates to the right scapula or back. This classic presentation, combined with the lack of cardiac markers and the dietary trigger, strongly suggests the gallbladder is the source of the pain.

Choice C rationale

Gastroesophageal reflux occurs when stomach acid backs up into the esophagus, causing a burning sensation in the chest known as heartburn. While it is often triggered by eating, it typically causes retrosternal burning rather than sharp right upper quadrant pain that radiates to the back. Reflux does not usually present with the severity and specific radiation pattern seen in biliary colic or cholecystitis, making it a less likely primary diagnosis for this specific patient.

Choice D rationale

Appendicitis is the inflammation of the vermiform appendix, typically presenting with periumbilical pain that later localizes to the right lower quadrant at McBurney's point. While it can cause nausea and vomiting, the pain is not usually triggered specifically by high-fat meals, nor does it typically radiate to the back from the right upper quadrant. The anatomical location of the pain in this scenario is too high for a standard presentation of acute appendicitis.

Choice A rationale

Acetylcholine is an excitatory neurotransmitter in the basal ganglia. In Parkinson's disease, there is a relative overactivity of acetylcholine because there is not enough dopamine to inhibit it. While the imbalance between acetylcholine and dopamine is crucial to the disease's symptoms, the primary disruption and the root cause of the pathology is the loss of dopamine. Anticholinergic medications are sometimes used to restore balance, but they do not address the primary neurochemical deficit.

Choice B rationale

Parkinson's disease is directly caused by the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. Dopamine is essential for the smooth, coordinated regulation of muscle movement via the basal ganglia. When dopamine levels fall by approximately 60 to 80 percent, the classic motor symptoms emerge. Most pharmacological treatments, such as Levodopa, aim to increase dopamine levels or mimic its action at the receptor site to alleviate bradykinesia, tremors, and muscle rigidity.

Choice C rationale

Serotonin is involved in mood, sleep, and appetite regulation. While patients with Parkinson's disease often suffer from depression and sleep disturbances due to secondary changes in serotonergic pathways, serotonin is not the primary neurotransmitter responsible for the motor dysfunction that defines the disease. The loss of serotonin-producing neurons may occur as the disease spreads to other brain regions, but it is considered a non-motor complication rather than the central cause of the disorder's hallmark signs.

Choice D rationale

Norepinephrine is produced by neurons that are also affected in Parkinson's disease, particularly in the locus coeruleus. This loss contributes to non-motor symptoms like orthostatic hypotension and fatigue. However, the cardinal motor features like bradykinesia and rigidity are specifically linked to the dopamine deficit. While norepinephrine plays a role in the overall clinical picture of autonomic dysfunction in Parkinson's, it is not the primary neurotransmitter whose disruption characterizes the core movement disorder.